China SXT Pharmaceuticals, Inc. (SXTC)

NASDAQ: SXTC · IEX Real-Time Price · USD
1.89
-0.06 (-2.83%)
May 26, 2022 3:59 PM EDT - Market closed

Balance Sheet (Annual)

Millions USD. Fiscal year is Apr - Mar.
Year20202019201820172016
Cash & Equivalents
13.367.299.290.660.07
Short-Term Investments
1.581.590.080.30
Cash & Cash Equivalents
14.948.879.370.960.07
Cash Growth
68.39%-5.34%875.21%1365.83%-
Receivables
5.034.744.52.963.9
Inventory
0.860.891.011.270.89
Other Current Assets
2.415.130.710.910.05
Total Current Assets
23.2319.6415.596.14.91
Property, Plant & Equipment
1.791.91.811.490.49
Goodwill and Intangibles
0.050.050.060.060.04
Other Long-Term Assets
9.480.110.010.010
Total Long-Term Assets
11.312.071.881.560.53
Total Assets
34.5521.717.477.665.43
Accounts Payable
13.61.944.172.411.82
Current Debt
0.046.690.260.390.3
Other Current Liabilities
4.943.641.891.581.46
Total Current Liabilities
18.5812.266.324.373.58
Long-Term Debt
0.010.040.0400
Total Long-Term Liabilities
0.010.040.0400
Total Liabilities
18.5912.36.364.373.58
Total Debt
0.046.720.30.390.3
Debt Growth
-99.35%2120.13%-21.36%27.45%-
Common Stock
25.3917.27.971.481.48
Retained Earnings
-9.95-7.23.081.540.36
Comprehensive Income
0.53-0.590.050.260.01
Shareholders' Equity
15.969.411.113.291.85
Total Liabilities and Equity
34.5521.717.477.665.43
Net Cash / Debt
14.92.159.070.58-0.24
Net Cash / Debt Growth
593.38%-76.31%1474.64%--
Net Cash Per Share
20.706.9535.282.30-0.95
Working Capital
4.657.379.271.731.33
Book Value Per Share
22.1830.4143.2013.147.41
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).